BridgeBio Pharma Ownership | Who Owns BridgeBio Pharma?

Overview Forecast RevenueFinancials Chart Transcripts

BridgeBio Pharma Ownership Summary

BridgeBio Pharma is owned by 97.89% institutional investors, 3.92% insiders. Vanguard group is the largest institutional shareholder, holding 8.85% of BBIO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.85% of its assets in BridgeBio Pharma shares.

BBIO Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	BridgeBio Pharma	97.89%	3.92%	-1.81%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.80%	11.85%	52.35%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	16.86M	8.85%	$1.29B
Blackrock funding, inc. /de	14.21M	7.20%	$1.06B
Kohlberg kravis roberts	13.26M	6.72%	$984.76M
Janus henderson group	13.18M	6.68%	$978.61M
Blackrock	12.45M	6.64%	$315.31M
Viking global investors lp	11.84M	6.00%	$879.42M
Farallon capital management	9.37M	4.75%	$695.48M
Aisling capital management lp	5.09M	2.58%	$377.95M
State street	4.93M	2.50%	$366.42M
Geode capital management	4.92M	2.49%	$371.93M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Aisling capital management lp	5.09M	79.35%	$377.95M
Kohlberg kravis roberts	13.26M	18.42%	$984.76M
Catalio capital management, lp	432.01K	6.70%	$32.08M
Frazier life sciences management	3.45M	6.59%	$256.06M
Cutter capital management, lp	560.34K	6.30%	$15.38M
First turn management	695.72K	5.77%	$51.66M
Boone capital management	228.83K	5.21%	$16.99M
Superstring capital management lp	88.66K	4.54%	$4.60M
Laurion capital management lp	1.26M	4.09%	$93.76M
Knott david m jr	90.00K	3.98%	$6.68M

Top Buyers

Holder	Shares	% Assets	Change
Citadel advisors	3.17M	0.04%	2.48M
Janus henderson group	13.18M	0.49%	2.18M
Blackrock	12.45M	0.01%	1.98M
Norges bank	1.53M	0.01%	1.53M
Jane street group	1.76M	0.02%	1.42M

Top Sellers

Holder	Shares	% Assets	Change
Brooklands fund management	-	-	-2.75M
Viking global investors lp	11.84M	2.46%	-2.55M
Macquarie group	-	-	-1.93M
Perceptive advisors	-	-	-1.22M
Capital research global investors	763.70K	0.01%	-1.17M

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	1.53M	0.01%	1.53M	$116.80M
Vanguard fiduciary trust	1.18M	0.02%	1.18M	$87.27M
T. rowe price investment management	1.05M	0.03%	1.05M	$54.63M
Diamant asset management	527.25K	0.38%	527.25K	$527.25M
Fiera capital	322.69K	0.08%	322.69K	$23.96M

Sold Out

Holder	Change
Dv trading	-1.00
Tortoise investment management	-1.00
Td private client wealth	-2.00
Creekmur asset management	-3.00
Financial gravity asset management	-3.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	483	1.90%	193,076,305	1.05%	97	0.97%	262	1.16%	138	-
Dec 31, 2025	140	-67.21%	32,651,635	-82.36%	17	0.18%	86	-61.78%	32	-76.30%
Sep 30, 2025	144	-63.36%	28,301,584	-85.01%	14	0.15%	78	-65.64%	46	-57.80%
Jun 30, 2025	392	13.29%	188,775,960	1.99%	99	1.05%	226	14.14%	109	32.93%
Mar 31, 2025	344	12.05%	185,144,507	4.79%	97	1.11%	196	24.05%	82	5.13%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	5.57M	2.85%	14.24K
Vanguard US Total Market Shares ETF	4.53M	2.38%	3.92K
Vanguard Small Cap Index	4.02M	2.05%	-8.76K
iShares Russell 2000 ETF	3.73M	1.90%	31.44K
SPDR® S&P Biotech ETF	2.40M	1.26%	5.36K
Vanguard Small Cap Growth Index Inv	2.25M	1.15%	-766.00
American Funds SMALLCAP World A	2.07M	1.09%	-596.87K
Vanguard Institutional Extnd Mkt Idx Tr	1.91M	0.98%	19.14K
Janus Henderson Enterprise D	1.91M	0.97%	225.89K
Janus Inst Mid Cap Growth CF	1.91M	0.97%	522.12K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 04, 2026	Kumar Neil	Chief Executive Officer	Sell	$1.08M
Jun 04, 2026	Kumar Neil	Chief Executive Officer	Sell	$30.72K
Jun 04, 2026	Kumar Neil	Chief Executive Officer	Sell	$144.58K
Jun 04, 2026	Kumar Neil	Chief Executive Officer	Sell	$95.35K
Jun 05, 2026	Kumar Neil	Chief Executive Officer	Sell	$480.34K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	27
2026 Q1	-	50
2025 Q4	-	50
2025 Q3	-	35
2025 Q2	-	16

BBIO Ownership FAQ

Who Owns BridgeBio Pharma?

BridgeBio Pharma shareholders are primarily institutional investors at 97.89%, followed by 3.92% insiders and -1.81% retail investors. The average institutional ownership in BridgeBio Pharma's industry, Biotech Stocks , is 35.80%, which BridgeBio Pharma exceeds.

Who owns the most shares of BridgeBio Pharma?

BridgeBio Pharma’s largest shareholders are Vanguard group (16.86M shares, 8.85%), Blackrock funding, inc. /de (14.21M shares, 7.20%), and Kohlberg kravis roberts (13.26M shares, 6.72%). Together, they hold 22.78% of BridgeBio Pharma’s total shares outstanding.

Does Blackrock own BridgeBio Pharma?

Yes, BlackRock owns 6.64% of BridgeBio Pharma, totaling 12.45M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 315.31M$. In the last quarter, BlackRock increased its holdings by 1.98M shares, a 18.93% change.

Who is BridgeBio Pharma’s biggest shareholder by percentage of total assets invested?

Aisling capital management lp is BridgeBio Pharma’s biggest shareholder by percentage of total assets invested, with 79.35% of its assets in 5.09M BridgeBio Pharma shares, valued at 377.95M$.

Who is the top mutual fund holder of BridgeBio Pharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of BridgeBio Pharma shares, with 2.85% of its total shares outstanding invested in 5.57M BridgeBio Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools